Baseline and interim 18F-FDG PET/CT metabolic parameters predict the efficacy and survival in patients with diffuse large B-cell lymphoma
The findings suggest that baseline TLG is a robust prognostic indicator for patients with DLBCL, particularly in early stages, while ΔTLG effectively distinguishes those with favorable outcomes in higher-risk groups. These metabolic parameters from 18F-FDG PET/CT could enhance treatment decision-making and patient management strategies.
Authors
- Lin Zeng (ORCID: https://orcid.org/0000-0002-0510-1754)
- Zhe Li (ORCID: https://orcid.org/0000-0002-3434-0885)
- Chengcheng Liao (ORCID: https://orcid.org/0000-0003-0408-6684)
- Xiaohong Tan (ORCID: https://orcid.org/0000-0003-4700-4562)
- Mei Huang (ORCID: https://orcid.org/0000-0002-5766-0718)
- Baoping Guo (ORCID: https://orcid.org/0000-0002-2256-9885)
- Hong Cen (ORCID: https://orcid.org/0000-0002-2883-7123)
- Qifeng Deng
- Qing Ke (ORCID: https://orcid.org/0000-0001-7415-8052)
- Da Zhou
- Mingyue Wang (ORCID: https://orcid.org/0009-0003-2673-837X)
Institutions
- Guangxi Medical University (CN)
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (CN)
- Guangxi University of Chinese Medicine (CN)
- Guigang City People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.3389/fonc.2024.1395824
- Citations
- 9
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.82
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Guangxi Medical University